| |
IA
|
DM
|
OA
|
Controls
|
|---|
| |
(n = 1,518)
|
(n = 11,959)
|
(n = 4,040)
|
(n = 158,439)
|
|---|
|
Mean age, years
|
60.3**
|
65.8**
|
69.8**
|
51.0
|
|
Female gender,%
|
64.1**
|
51.9*
|
68.7**
|
50.4
|
|
AMI,%
|
1.8**
|
2.8**
|
1.5**
|
0.7
|
|
TIA,%
|
2.0**
|
2.2**
|
2.0**
|
0.6
|
|
CVA,%
|
3.0**
|
3.7**
|
2.7**
|
0.9
|
|
Total CVD,%
|
6.5**
|
8.1**
|
5.8**
|
2.0
|
|
Hypertension,%
|
30.9**
|
47.7**
|
38.5**
|
13.3
|
|
Hypercholesterolemia,%
|
10.8**
|
24.0**
|
13.3**
|
4.8
|
|
Use of anti-hypertensive agents,%
|
36.4**
|
60.6**
|
45.0**
|
14.6
|
|
Use of statins,%
|
15.7**
|
48.8**
|
20.0**
|
6.0
|
|
Inflammatory arthritis,%
|
—
|
1.5
|
1.6
|
—
|
|
Diabetes mellitus,%
|
11.5
|
—
|
16.5
|
—
|
|
Osteoarthritis,%
|
4.4
|
5.6
|
—
|
—
|
- * p < 0.01; ** p < 0.001 (compared to controls) DM, diabetes mellitus; IA, inflammatory arthritis; OA, knee- and/or hip osteoarthritis; AMI, acute myocardial infarction; TIA, transient ischemic attack; CVA, cerebrovascular accident; CVD, cardiovascular disease.
